Riesgo de hemorragia digestiva con aspirina y antiagregantes plaquetarios

Zundorf, 1997 Esmatjes, 2004, Consumo de ácido acetilsalicílico en pacientes con diabetes mellitus, Med Clin (Barc), 122, 96, 10.1016/S0025-7753(04)74155-X Campbell, 2007, Aspirin dose for the prevention of cardiovascular disease: a systematic review, JAMA, 297, 2018, 10.1001/jama.297.18.2018 Rivkin, 2007, Admissions to a medical intensive care unit related to adverse drug reactions, Am J Health Syst Pharm, 64, 1840, 10.2146/ajhp060641 1994, Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81 2002, Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 Lee, 1994, Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury, Ann Intern Med, 120, 184, 10.7326/0003-4819-120-3-199402010-00002 Yeomans, 2005, Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin, Aliment Pharmacol Ther, 22, 795, 10.1111/j.1365-2036.2005.02649.x Chowdhury, 2001, Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study, Indian J Gastroenterol, 20, 227 Laine, 2004, Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a doubleblind trial, Gastroenterology, 127, 395, 10.1053/j.gastro.2004.05.001 Pirmohamed, 2004, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, 329, 15, 10.1136/bmj.329.7456.15 Weil, 1995, Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, 310, 827, 10.1136/bmj.310.6983.827 Derry, 2000, Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis, BMJ, 321, 1183, 10.1136/bmj.321.7270.1183 García Rodríguez, 2001, Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies, Br J Clin Pharmacol, 52, 563, 10.1046/j.0306-5251.2001.01476.x Weil, 1995, Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, 310, 827, 10.1136/bmj.310.6983.827 Lanas, 2000, Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding, N Engl J Med, 343, 834, 10.1056/NEJM200009213431202 Ibañez, 2006, Upper gastrointestinal bleeding associated with antiplatelet drugs, Aliment Pharmacol Ther, 23, 235, 10.1111/j.1365-2036.2006.02759.x De Abajo, 2001, Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations, BMC Clin Pharmacol, 1, 1, 10.1186/1472-6904-1-1 Kelly, 1996, Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product, Lancet, 348, 1413, 10.1016/S0140-6736(96)01254-8 Lanas, 2005, A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal anti-inflammatory drug use, Am J Gastroenterol, 100, 1685, 10.1111/j.1572-0241.2005.41833.x McQuaid, 2006, Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials, Am J Med, 119, 624, 10.1016/j.amjmed.2005.10.039 Laine, 2001, Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient, Gastroenterology, 120, 594, 10.1053/gast.2001.21907 Lanas, 2000, Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding, N Engl J Med, 343, 834, 10.1056/NEJM200009213431202 Serrano, 2002, Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases, Aliment Pharmacol Ther, 16, 1945, 10.1046/j.1365-2036.2002.01355.x Chan, 2001, Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen, N Engl J Med, 344, 967, 10.1056/NEJM200103293441304 Lanas, 2002, Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin, Aliment Pharmacol Ther, 16, 779, 10.1046/j.1365-2036.2002.01230.x Patrono, 2005, Low-dose aspirin for the prevention of atherothrombosis, N Engl J Med, 353, 2373, 10.1056/NEJMra052717 1988, Thrombosis Prevention Trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk, Lancet, 351, 233 Johnson, 2002, Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study, J Vasc Surg, 35, 413, 10.1067/mva.2002.121847 Nielsen, 2001, Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study, Am J Med, 111, 541, 10.1016/S0002-9343(01)00941-X Lanas, 2006, Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations, Gut, 55, 1731, 10.1136/gut.2005.080754 Sorensen, 2000, Risk of upper gastrointestinal bleeding associated with use of lowdose aspirin, Am J Gastroenterol, 95, 2218, 10.1111/j.1572-0241.2000.02248.x Lanas, 2005, Coxibs, NSAIDs, aspirin, PPIs and the risks of upper GI bleeding in common clinical practice, Gastroenterology, 128, 629 Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study, JAMA, 284, 1247, 10.1001/jama.284.10.1247 Schnitzer, 2004, Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial, Lancet, 364, 665, 10.1016/S0140-6736(04)16893-1 Singh, 2006, Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study, Am J Med, 119, 255, 10.1016/j.amjmed.2005.09.054 Sopena, 2007, How to advise aspirin use in patients who need NSAIDs, Curr Pharm Des, 13, 2248, 10.2174/138161207781368837 Huang, 2002, Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis, Lancet, 359, 14, 10.1016/S0140-6736(02)07273-2 Papatheodoridis, 2006, Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review, Clin Gastroenterol Hepatol, 4, 130, 10.1016/j.cgh.2005.10.006 Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 1996, A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Lanas, 2007, Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants, Am J Gastroenterol, 102, 507, 10.1111/j.1572-0241.2006.01062.x Rostom, 2004, Prevention of NSAID-induced gastroduodenal ulcers, Cochrane Database Syst Rev, 4, 1 Lai, 2002, Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use, N Engl J Med, 346, 2033, 10.1056/NEJMoa012877 Chan, 2005, Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding, N Engl J Med, 352, 238, 10.1056/NEJMoa042087 Lai, 2006, Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications, Clin Gastroenterol Hepatol, 4, 860, 10.1016/j.cgh.2006.04.019 Lanas, 2002, Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin, Aliment Pharmacol Ther, 16, 779, 10.1046/j.1365-2036.2002.01230.x Chan, 2005, Eradication of H. pylori for the prevention of recurrent ulcer bleeding in high-risk aspirin users: a 4-year prospective cohort study, Gastroenterology, 128, 835 Lanas, 2007, Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly, Drugs Aging, 24, 121, 10.2165/00002512-200724020-00004 García Rodríguez, 2001, Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies, Br J Clin Pharmacol, 52, 563, 10.1046/j.0306-5251.2001.01476.x